TF and cancer: As the underlying principle, namely the systemic activation of the coagulation system by TF+EVs, is basically accepted, one of the reasons for the lack of clinical collation in all cancers might be related to the methodologies used in different studies (Gardiner et al. 2015; Thaler et al. 2012).